We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Reasons Why You Should Avoid Betting on IDEX Stock Right Now
Read MoreHide Full Article
Key Takeaways
IDEX faces softness in FMT, hurt by weak agriculture, energy, water and semiconductor markets.
Selling, general and administrative expenses rose 11.4% year over year in Q2 2025.
Strengthening U.S. dollar pressures margins abroad, adding forex risks to IDEX's performance.
IDEX Corporation (IEX - Free Report) failed to impress investors with its recent operational performance due to softness in the Fluid & Metering Technologies (FMT) segment and increasing selling, general and administrative expenses. Also, foreign currency headwind is an added uncertainty.
IEX currently carries a Zacks Rank #4 (Sell). In the past year, the stock has lost 18.3% against the industry’s 9.4% growth.
Image Source: Zacks Investment Research
Let’s discuss the factors that are likely to continue taking a toll on this company.
Business Weakness: The company is witnessing softness in the FMT segment. Weakness in the agriculture, energy, water and semiconductor businesses is concerning for it. Also, soft chemical businesses, due to weakness in the European chemicals market, is acting as a headwind for the segment’s performance. The FMT segment’s organic revenues decreased 2% year over year in the second quarter of 2025.
Rising Expenses: IDEX has been dealing with the adverse impacts of rising operating costs and expenses. The company’s selling, general and administrative expenses grew 11.4% year over year in the second quarter of 2025. Increasing amortization expenses and professional services spending are raising the selling, general and administrative expenses. As a percentage of sales, it increased 90 bps to 23.5% in the same period. Also, the company’s cost of sales recorded an increase of 7.4% year over year in the second quarter.
Forex Woes: IDEX’s international presence keeps it exposed to the risk of adverse currency fluctuations. This is because a strengthening U.S. dollar is likely to require the company to either raise prices or contract profit margins in locations outside the United States. Thus, adverse currency movements are a worry.
FLS delivered a trailing four-quarter average earnings surprise of 5.5%. In the past 60 days, the Zacks Consensus Estimate for Flowserve’s 2025 earnings has increased 4.7%.
Crane Company (CR - Free Report) presently carries a Zacks Rank #2 (Buy). The company delivered a trailing four-quarter average earnings surprise of 7.5%.
In the past 60 days, the consensus estimate for CR’s 2025 earnings has increased 4%.
Dover Corporation (DOV - Free Report) presently carries a Zacks Rank of 2. DOV delivered a trailing four-quarter average earnings surprise of 4%.
In the past 60 days, the consensus estimate for DOV’s 2025 earnings has inched up 1.2%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Reasons Why You Should Avoid Betting on IDEX Stock Right Now
Key Takeaways
IDEX Corporation (IEX - Free Report) failed to impress investors with its recent operational performance due to softness in the Fluid & Metering Technologies (FMT) segment and increasing selling, general and administrative expenses. Also, foreign currency headwind is an added uncertainty.
IEX currently carries a Zacks Rank #4 (Sell). In the past year, the stock has lost 18.3% against the industry’s 9.4% growth.
Image Source: Zacks Investment Research
Let’s discuss the factors that are likely to continue taking a toll on this company.
Business Weakness: The company is witnessing softness in the FMT segment. Weakness in the agriculture, energy, water and semiconductor businesses is concerning for it. Also, soft chemical businesses, due to weakness in the European chemicals market, is acting as a headwind for the segment’s performance. The FMT segment’s organic revenues decreased 2% year over year in the second quarter of 2025.
Rising Expenses: IDEX has been dealing with the adverse impacts of rising operating costs and expenses. The company’s selling, general and administrative expenses grew 11.4% year over year in the second quarter of 2025. Increasing amortization expenses and professional services spending are raising the selling, general and administrative expenses. As a percentage of sales, it increased 90 bps to 23.5% in the same period. Also, the company’s cost of sales recorded an increase of 7.4% year over year in the second quarter.
Forex Woes: IDEX’s international presence keeps it exposed to the risk of adverse currency fluctuations. This is because a strengthening U.S. dollar is likely to require the company to either raise prices or contract profit margins in locations outside the United States. Thus, adverse currency movements are a worry.
Stocks to Consider
Some better-ranked companies are discussed below.
Flowserve Corporation (FLS - Free Report) currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
FLS delivered a trailing four-quarter average earnings surprise of 5.5%. In the past 60 days, the Zacks Consensus Estimate for Flowserve’s 2025 earnings has increased 4.7%.
Crane Company (CR - Free Report) presently carries a Zacks Rank #2 (Buy). The company delivered a trailing four-quarter average earnings surprise of 7.5%.
In the past 60 days, the consensus estimate for CR’s 2025 earnings has increased 4%.
Dover Corporation (DOV - Free Report) presently carries a Zacks Rank of 2. DOV delivered a trailing four-quarter average earnings surprise of 4%.
In the past 60 days, the consensus estimate for DOV’s 2025 earnings has inched up 1.2%.